Results 11 to 20 of about 426,014 (383)
Autoimmune hemolytic anemia [PDF]
Hematology, 2018 AbstractThe diagnosis of autoimmune hemolytic anemia (AIHA) can be made with a stepwise approach that aims to identify laboratory and clinical evidence of hemolysis and then determine the immune nature of hemolysis with the direct anti-globulin test. Once alternative causes for these findings have been excluded, AIHA is established, and the clinician ...
Quentin A. Hill, Anita J. Hill
openaire +4 more sources
BMC Pharmacology and Toxicology, 2018 Background Drug induced immune hemolytic anemia (DIIHA) is a rare complication and often underdiagnosed. DIIHA is frequently associated with a bad outcome, including organ failure and even death. For the last decades, ceftriaxone has been one of the most
Hans Benno Leicht +5 more
doaj +2 more sources
Annals of Hematology, 2022 COVID-19 is a global pandemic triggered by the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 entry point involves the interaction with angiotensin-converting enzyme 2 (ACE2) receptor, CD147, and erythrocyte Band3 protein ...
H. Al-kuraishy +4 more
semanticscholar +1 more source
Autoimmune hemolytic anemia: causes and consequences
Expert Review of Clinical Immunology, 2022 Introduction Autoimmune hemolytic anemia (AIHA) is classified according to the direct antiglobulin test (DAT) and thermal characteristics of the autoantibody into warm and cold forms, and in primary versus secondary depending on the presence of ...
B. Fattizzo, W. Barcellini
semanticscholar +1 more source
How I treat warm autoimmune hemolytic anemia.
Blood, 2021 Warm autoimmune hemolytic anemia (wAIHA) is caused by increased erythrocyte destruction by IgG autoantibodies, with or without complement activation.
W. Barcellini, B. Fattizzo
semanticscholar +1 more source
How I treat microangiopathic hemolytic anemia in patients with cancer
Blood, 2021 Diagnosis and treatment of acquired hemolytic anemia can be challenging. In this How I Treat series, edited by Mario Cazzola, clinical experts discuss their approaches to the treatment of patients with 4 different classes of acquired hemolytic anemia.
M. Thomas, M. Scully
semanticscholar +1 more source
Autoimmune Hemolytic Anemia in the Pediatric Setting
Journal of Clinical Medicine, 2021 Autoimmune hemolytic anemia (AIHA) is a rare disease in children, presenting with variable severity. Most commonly, warm-reactive IgG antibodies bind erythrocytes at 37 °C and induce opsonization and phagocytosis mainly by the splenic macrophages ...
A. Voulgaridou, T. Kalfa
semanticscholar +1 more source
Hemolytic Anemia Complicating COVID-19 Infection
Journal of Hematology, 2021 Coronavirus disease 2019 (COVID-19) has been associated with a spectrum of reported hematological complications ranging from immune cytopenias to thromboembolic manifestations of coagulopathy.
Abeer N. Abouyabis, Grace Thompson Bell
semanticscholar +1 more source
Definitions, 2020 Copyright 2013, Turner White Communications, Inc., Strafford Avenue, Suite 220, Wayne, PA 19087-3391, www.turner-white.com. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by
Bruce M. White +5 more
semanticscholar +1 more source
New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia
Frontiers in Immunology, 2020 Autoimmune hemolytic anemias mediated by cold agglutinins can be divided into cold agglutinin disease (CAD), which is a well-defined clinicopathologic entity and a clonal lymphoproliferative disorder, and secondary cold agglutinin syndrome (CAS), in ...
S. Berentsen
semanticscholar +1 more source